Pacific Edge

New Zealand
Dunedin, Otago, New Zealand, 9016

Company profile

Pacific Edge company profile

Pacific Edge is a cancer diagnostics company. They specialise in discovering, building and commercialising innovative cancer diagnostic tests that can contribute to a clinically meaningful difference in the detection and management of cancer. Their products are built from their proprietary genetic databases, which are used to identify diagnostic and prognostic biomarkers for cancer.

Business identity

Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$1M-$10M
Founded
2001-01-01, Year

Headquarters

Postal code
9016
Country code
NZ
Continent
Oceania

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
6
Last funding
Grant / $13,377 / 2024-07-19
Last equity funding
Post IPO Equity
Investors
2
Lead investors
2
Articles
37
Exited on
2003-02-07

Founders and investors

Lead investors

Callaghan InnovationManchester Capital Management

Investors

Callaghan InnovationManchester Capital Management